NCT03674242 2022-08-01
Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2)
ERYtech Pharma
Phase 2/3 Terminated
ERYtech Pharma
ERYtech Pharma
Memorial Sloan Kettering Cancer Center
Instituto do Cancer do Estado de São Paulo